SELIL and HRD1 are involved in the degradation of unassembled secretory Ig-μ chains

被引:35
作者
Cattaneo, Monica [1 ]
Otsu, Mieko [2 ]
Fagioli, Claudio [2 ]
Martino, Simone [3 ]
Lotti, Lavinia Vittoria [3 ]
Sitia, Roberto [2 ,4 ]
Biunno, Ida [1 ,5 ]
机构
[1] ITB CNR, I-20090 Milan, Italy
[2] DiBiT San Raffaele Sci Inst, Milan, Italy
[3] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[4] Univ Vita Salute San Raffaele Sci Inst, Milan, Italy
[5] BioREP, Milan, Italy
关键词
D O I
10.1002/jcp.21364
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
When expressed in the absence of light chains, secretory I1g-mu chains (R,) undergo endoplasmic reticulum associated degradation (ERAD). This process involves the recognition of terminally misfolded or unassembled molecules, their retro-translocation across the ER membrane and ubiquitination for degradation by cytosolic proteasomes. The molecular components of the ERAD pathway and their coordination remain largely unknown. Here we employed co-immunoprecipitation, silencing or over-expression assays to show that SELIL and HRD1 are involved in the degradation of unassembled Ig-mu(s), but have minor effects on another substrate, TCR-alpha. SELIL and HRD1 localize in the early secretory apparatus and are induced by ER stress and during B cell differentiation, concomitantly with the onset of massive IgM secretion. These findings reveal a role for SELIL and HRD1 in IgM quality control.
引用
收藏
页码:794 / 802
页数:9
相关论文
共 56 条
[1]   High ER stress in β-cells stimulates intracellular degradation of misfolded insulin [J].
Allen, JR ;
Nguyen, LX ;
Sargent, KEG ;
Lipson, KL ;
Hackett, A ;
Urano, F .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 324 (01) :166-170
[2]   Sequential steps and checkpoints in the early exocytic compartment during secretory IgM biogenesis [J].
Anelli, Tiziana ;
Ceppi, Stefania ;
Bergamelli, Leda ;
Cortini, Margherita ;
Masciarelli, Silvia ;
Valetti, Caterina ;
Sitia, Roberto .
EMBO JOURNAL, 2007, 26 (19) :4177-4188
[3]   An amphipathic helix targets serum and glucocorticoid-induced kinase 1 to the endoplasmic reticulum-associated ubiquitin-conjugation machinery [J].
Arteaga, Maria Francisca ;
Wang, Lin ;
Ravid, Tommer ;
Hochstrasser, Mark ;
Canessa, Cecilia M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (30) :11178-11183
[4]   Protein profile changes in the human breast cancer cell line MCF-7 in response to SEL1L gene induction [J].
Bianchi, L ;
Canton, C ;
Bini, L ;
Orlandi, R ;
Ménard, S ;
Armini, A ;
Cattaneo, M ;
Pallini, V ;
Bernardi, LR ;
Biunno, I .
PROTEOMICS, 2005, 5 (09) :2433-2442
[5]   SEL1L a multifaceted protein playing a role in tumor progression [J].
Biunno, Ida ;
Cattaneo, Monica ;
Orlandi, Rosaria ;
Canton, Cristina ;
Biagiotti, Laura ;
Ferrero, Stefano ;
Barberis, Massimo ;
Pupa, Serenella M. ;
Scarpa, Aldo ;
Menard, Sylvie .
JOURNAL OF CELLULAR PHYSIOLOGY, 2006, 208 (01) :23-38
[6]   Conformational disease [J].
Carrell, RW ;
Lomas, DA .
LANCET, 1997, 350 (9071) :134-138
[7]   Distinct ubiquitin-ligase complexes define convergent pathways for the degradation of ER proteins [J].
Carvalho, Pedro ;
Goder, Veit ;
Rapoport, Tom A. .
CELL, 2006, 126 (02) :361-373
[8]   SEL1L affects human pancreatic cancer cell cycle and invasiveness through modulation of PTEN and genes related to cell-matrix interactions [J].
Cattaneo, M ;
Fontanella, E ;
Canton, C ;
Delia, D ;
Biunno, I .
NEOPLASIA, 2005, 7 (11) :1030-1038
[9]   Identification of a region within SEL1L protein required for tumour growth inhibition [J].
Cattaneo, M ;
Canton, C ;
Albertini, A ;
Biunno, I .
GENE, 2004, 326 :149-156
[10]   SEL1L expression in pancreatic adenocarcinoma parallels SMAD4 expression and delays tumor growth in vitro and in vivo [J].
Cattaneo, M ;
Orlandini, S ;
Beghelli, S ;
Moore, PS ;
Sorio, C ;
Bonora, A ;
Bassi, C ;
Talamini, G ;
Zamboni, G ;
Orlandi, R ;
Ménard, S ;
Bernardi, LR ;
Biunno, I ;
Scarpa, A .
ONCOGENE, 2003, 22 (41) :6359-6368